Protein release from polyphosphazene matrices

Advanced Drug Delivery Reviews

Volumn 31, Issue 3, 1998, Pages 185-196

  Andrianov, Alexander K ^a   Payne, Lendon G ^a  

^a Virus Research Institute Inc Cambridge   (United States)

Author keywords

Biodegradation; Controlled release; Hydrogels; Polyphosphazenes; Proteins

Indexed keywords

BIODEGRADATION; HYDROGELS; MECHANICAL PERMEABILITY; METALLORGANIC POLYMERS; MOLECULAR STRUCTURE; PHOSPHORUS COMPOUNDS; PROTEINS;

POLYPHOSPHAZENE;

CONTROLLED DRUG DELIVERY;

ADJUVANT; BETA GALACTOSIDASE; BOVINE SERUM ALBUMIN; DRUG CARRIER; FLUORESCEIN ISOTHIOCYANATE; FREUND ADJUVANT; INFLUENZA VACCINE; MICROSPHERE; ORGANOMETALLIC COMPOUND; POLYGLACTIN; POLYLYSINE; POLYMER; POLYPHOSPHAZENE; POLY[DI(CARBOXYLATOPHENOXY)PHOSPHAZENE]; PROTEIN; TETANUS TOXOID; UNCLASSIFIED DRUG; VACCINE; VIRUS VACCINE;

ARTICLE; BIODEGRADATION; CONTROLLED RELEASE FORMULATION; DRUG DELIVERY SYSTEM; HYDROGEL; IMMUNOGENICITY; MICROENCAPSULATION; PRIORITY JOURNAL; PROTEIN SECRETION;

EID: 0032482167     PISSN: 0169409X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0169-409X(97)00122-1     Document Type: Review

References (51)

1. H.R. Allcock, Polyphosphazenes as new biomedical and bioactive materials, in: M. Chasin, R. Langer (Eds.), Biodegradable Polymers as Drug Delivery Systems, Marcel Dekker, New York, 1990, pp. 163-193.
2. A.G. Scopelianos, Polyphosphazenes as new biomaterials, in: W.S.W. Shalaby (Eds.), Biomedical Polymers Hanser, 1994, pp. 153-171.
3. J.E. Mark, H.R. Allcock, R. West, Inorganic Polymers, Prentice Hall, Englewood Cliffs, NJ, 1992, pp. 61-140.
4. 2. 1. Kinetics and reaction mechanism, Macromolecules 25 (1992) 1254-1258.
5. H.R. Allcock, C.A. Crane, C.T. Morrissey, J.M. Nelson, S.D. Reeves, C.H. Honeyman, I. Manners, 'Living' cationic polymerization of phosphoranimines as an ambient temperature route to polyphosphazenes with controlled molecular weights, Macromolecules 29 (1996) 7740-7747.
6. H.R. Allcock, Y.B. Kim, Synthesis, characterization, and modification of poly(organophosphazenes) with both 2,2,2-trifluoroethoxy and phenoxy side groups, Macromolecules 27 (1994) 3933-3942.
7. R.H. Neilson, P. Wisian-Neilson, Poly(alkyl/arylphosphazene) and their precursors, Chem. Rev. 88 (1988) 541-561.
8. K. Matyjaszewski, Preparation of inorganic and organometallic polymers with controlled structures, J. Inorg. Org. Polymers 2 (1992) 5-27.
9. H.R. Allcock, Water-soluble polyphosphazenes and their hydrogels, in: J.E. Glass (Ed.), Hydrophilic Polymers: Performance with Environmental Acceptance, ACS, 1996, pp. 3-29.
10. R. Langer, New methods of drug delivery, Science 249 (1990) 1527-1533.
11. H.R. Allcock, T.J. Fuller, K. Matsumura, Hydrolysis pathways for aminophosphazenes, Inorg. Chem. 21 (1982) 515-521.
12. H.R. Allcock, T.J. Fuller, D.P. Mack, K. Matsumura, K.M. Smeltz, Synthesis of poly[(amino acid alkyl ester)phosphazenes]. Macromolecules 10 (1977) 824-830.
13. C.T. Laurencin, H.J. Koh, T.X. Neenan, H.R. Allcock, R. Langer, Controlled release using a new bioerodible polyphosphazene matrix system, J. Biomed. Mater. Res. 21 (1987) 1231-1246.
14. T. Tanigami, H. Ohta, R. Orii, K. Yamaura, S. Matsuzawa, Degradation of poly[bis(ethylamino)phosphazene] in aqueous solution. J. Inorg. Org. Polymers 5 (1995) 135-153.
15. H.R. Allcock, J.Y. Cheng, Poly(organophosphazenes) with oligopeptides as side groups: prospective biomaterials, Macromolecules 24 (1991) 993-999.
16. H.R. Allcock, S.R. Pucher, A.G. Scopelianos, Poly[(amino acid ester)phosphazenes] as substrates for the controlled release of small molecules, Biomaterials 15 (1994) 563-569.
17. E.M. Ruiz, C.A. Ramirez, M.A. Aponte, G.V. BarbosaCanovas, Degradation of poly[(bis(glycine ethyl ester)phosphazene] in aqueous media, Biomaterials 14 (1993) 491-496.
18. J. Crommen, J. Vandorpe, E. Schacht, Degradable polyphosphazenes for biomedical applications, J. Control. Release 24 (1993) 167-180.
19. H.R. Allcock, S.R. Pucher, A.G. Scopelianos, Poly[(amino acid ester)phosphazenes]: synthesis, crystallinity, and hydrolytic sensitivity in solution and the solid state, Macromolecules 27 (1994) 1071-1075.
20. E. Schacht, J. Vandorpe, J. Crommen, L. Seymour, Biodegradable Polyphosphazenes for Biomedical Applications, 5th Iketani Conf. Biomed. Polym. Kagoshima, Japan, in: Advances in Biomaterials, Biomedical Engineering and Drug Delivery Systems, Springer, Tokyo, 1995, pp. 81-85.
21. N.A. Peppas, A.R. Khare, Preparation, structure and diffusional behavior of hydrogels in controlled release, Adv. Drug Del. Rev. 11 (1993) 1-35.
22. K. Park, W.S.W. Shalaby, H. Park, Biodegradable Hydrogels for Drug Delivery, Technomic, Lancaster, 1993, p. 252.
23. H.R. Allcock, P.E. Austin, T.X. Neenan, J.T. Sisko, P.M. Blonsky, D.F. Shriver, Polyphosphazenes with etheric side groups: prospective biomedical and solid electrolyte polymers, Macromolecules 19 (1986) 1508-1512.
24. H.R. Allcock, S. Kwon, G.H. Riding, R.G. Fitzpatrick, J.L. Bennett, Hydrophilic polyphosphazenes as hydrogels: radiation cross-linking and hydrogel characteristics of poly[bis(methoxyethoxyethoxy)phosphazene], Biomaterials 9 (1988) 509-512.
25. H.R. Allcock, G.K. Dudley, Lower critical solubility temperature study of alkyl ether based polyphosphazenes, Macromolecules 29 (1996) 1313-1319.
26. C.J. Nelson, W.D. Coggio, H.R. Allcock, Ultraviolet radiation-induced cross-linking of poly[bis(2-(2-methoxyethoxy)ethoxy)phosphazene], Chem. Mater. 3 (1991) 787-788.
27. H.R. Allcock, S. Kwon, An ionically cross-linkable polyphosphazene: poly[bis(carboxylatophenoxy)phosphazene] and its hydrogel and membranes, Macromolecules 22 (1989) 75-79.
28. S. Cohen, M.C. Baño, K.B. Visscher, M. Chow, H.R. Allcock, R. Langer, Ionically cross-linkable polyphosphazene: a novel polymer for microencapsulation, J. Am. Chem. Soc. 112 (1990) 7832-7833.
29. M.C. Baño, S. Cohen, K.B. Visscher, H.R. Allcock, R. Langer, A novel synthetic method for hybridoma cell encapsulation, BioTechnology 9 (1991) 468-471.
30. A.K. Andrianov, S. Cohen, K.B. Visscher, L.G. Payne, H.R. Allcock, R. Langer, Controlled release using ionotropic polyphosphazene hydrogels, J. Control. Release 27 (1993) 69-77.
31. L.G. Payne, S.A. Jenkins, A.K. Andrianov, R. Langer, B.E. Roberts, Xenobiotic polymers as vaccine vehicles, in: J. Mestecky, J.R. McGee (Eds.), Advances in Mucosal Immunology, Plenum Press, New York, 1995, pp. 1475-1480.
32. L.G. Payne, S.A. Jenkins, A.K. Andrianov, B.E. Roberts, Water-soluble phosphazene polymers for parenteral and mucosal vaccine delivery, in: M.F. Powell, M.J. Newman (Eds.), Vaccine Design, Plenum Press, New York, 1995, pp. 473-493.
33. A.K. Andrianov, L.G. Payne, Polyphosphazene hydrogel microspheres for protein delivery, in: S. Cohen, H. Bernstein (Eds.), Microparticulate Systems for the Delivery of Proteins and Vaccines, Marcel Dekker, New York, 1996, pp. 127-147.
34. A.K. Andrianov, M.P. LeGolvan, Characterization of poly[di(carboxylatophenoxy)phosphazene] by an aqueous gel permeation chromatography, J. Appl. Polymer Sci. 60 (1996) 2289-2295.
35. G. Masci, S. Contadini, V. Crescenzi, M. Dentini, Solution characterization of a polyphosphazene polyelectrolyte, Polymer Preprints 34 (1993) 1067-1068.
36. A.K. Andrianov, J.R. Sargent, S.S. Sule, M.P. LeGolvan, L.G. Payne, Water-soluble ionic copolymers with polyphosphazene backbone as materials for controlled release technologies, ACS Polym. Mater. Sci. Eng. 76 (1997) 367-368.
37. A.K. Andrianov, M.P. LeGolvan, S.S. Sule, L.G. Payne, Degradation of poly[di(carboxylatophenoxy)phosphazene] in aqueous solution, ACS Polym. Mater. Sci. Eng. 76 (1997) 369-370.
38. A.K. Andrianov, J. Chen, L.G. Payne, Preparation of polyphosphazene hydrogel microspheres by coacervation, ACS Polym. Mater. Sci. Eng. 76 (1997) 365-366.
39. H.R. Allcock, A.M.A. Ambrosio, Synthesis and characterization of pH-sensitive poly(organophosphazene) hydrogels, Biomaterials 17 (1996) 2295-2302.
40. A.K. Andrianov, L.G. Payne, K.B. Visscher, H.R. Allcock, R. Langer, Hydrolytic degradation of ionically cross-linked polyphosphazene microspheres, J. Appl. Polymer Sci. 53 (1994) 1573-1578.
41. A. Grosse-Sommer, R.K. Prud'homme, Degradable phosphazene-crosslinked hydrogels, J. Control. Release 40 (1996) 261-267.
42. M. Donbrow, Microcapsules and Nanoparticles in Medicine and Pharmacy, CRC Press, Boca Raton, 1992, 347 p.
43. J.M. Goedemoed, E.H.G. Mense, K. de Groot, A.M.E. Claessen, R.J. Scheper, Development of injectable antitumor microspheres based on polyphosphazene, J. Control. Release 170 (1991) 245-258.
44. S.M. Ibim, A.A. Ambrosio, D. Larrier, H.R. Allcock, C.T. Laurencin, Controlled macromolecule release from poly(phosphazene) matrices, J. Control. Release 40 (1996) 31-39.
45. V.A. Kabanov, A.B. Zezin, Water-soluble nonstoichiometric polyelectrolyte complexes: a new class of synthetic polyelectrolytes, Soviet Sci. Rev., Sect. B. Chem. Rev. 4 (1982) 207-282.
46. E. Tsuchida, K. Abe, Polyelectrolyte Complexes, in: A.D. Wilson (Ed.), Developments in Ionic Polymers - 2, Elsevier, New York, 1986, pp. 191-266.
47. J.H. Eldridge, R.M. Gilley, J.K. Staas, Z. Moldoveanu, J.A. Muelbroek, T.R. Tice, Biodegradable microspheres: vaccine delivery system for oral immunization, Curr. Top. Microbiol. Immunol. 156 (1989) 59-66.
48. J.H. Eldridge, J.K. Staas, J.A. Meulbroek, T.R. Tice, R.M. Gilley, Biodegradable and biocompatible poly(DL-lactide-coglycolide) microspheres as an adjuvant for staphylococcal enterotoxin B toxoid which enhances the level of toxinneutralizing antibodies, Infect. Immun. 59 (1991) 2978-2986.
49. L.G. Payne, S.A. Jenkins, A.L. Woods, E.M. Grand, W.E. Geribo, J.R. Loebelenz, A.K. Andrianov, B.E. Roberts, Poly[di(carboxylatophenoxy)phosphazene] (PCPP) is a potent immunoadjuvant for an influenza vaccine, Vaccine Res. (1997) (in press).
50. L.G. Payne, G. Van Nest, G.L. Barchfeld, G.R. Siber, R.K. Gupta, S.A. Jenkins, The utility of PCPP as a parenteral adjuvant for diverse antigens, in: L. Haaheim (Ed.), Modulation of the Immune Response to Vaccine Antigens, International Association of Biological Standardization, Geneva, 1997.
51. Y. Lu, M. Salvato, D. Pauza, J. Li, J. Sodroski, K. Manson, M. Wyand, N. Letvin, F. Vogel, A. Schultz, S. Jenkins, N. Touzjian, C. Chutkowski, N. Kushner, M. LeFaile, L.G. Payne, B. Roberts, Utility of SHIV for testing HIV1 vaccine candidates in macaques, J. AIDS Hum. Retrovirol. 12 (1996) 99-106.